1. Home
  2. WLK vs RDY Comparison

WLK vs RDY Comparison

Compare WLK & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westlake Corporation

WLK

Westlake Corporation

HOLD

Current Price

$70.33

Market Cap

10.3B

Sector

Industrials

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$11.85

Market Cap

11.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLK
RDY
Founded
1986
1984
Country
United States
India
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3B
11.8B
IPO Year
2004
2001

Fundamental Metrics

Financial Performance
Metric
WLK
RDY
Price
$70.33
$11.85
Analyst Decision
Buy
Strong Buy
Analyst Count
15
1
Target Price
$106.87
$16.90
AVG Volume (30 Days)
975.2K
2.9M
Earning Date
05-05-2026
05-12-2026
Dividend Yield
1.90%
0.52%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,170,000,000.00
N/A
Revenue This Year
$5.51
$7.72
Revenue Next Year
$3.74
$3.50
P/E Ratio
N/A
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$56.33
$11.36
52 Week High
$124.23
$15.67

Technical Indicators

Market Signals
Indicator
WLK
RDY
Relative Strength Index (RSI) 24.28 32.69
Support Level $56.33 $11.36
Resistance Level $79.57 $14.08
Average True Range (ATR) 2.17 0.27
MACD -0.17 -0.07
Stochastic Oscillator 9.33 28.93

Price Performance

Historical Comparison
WLK
RDY

About WLK Westlake Corporation

Westlake is a forward-integrated commodity chemicals firm based in Houston. It began as a single low-density polyethylene plant and expanded its capabilities to include ethylene, vinyl chloride monomers, and polyvinyl chloride over the next two decades. The acquisition of Axiall in 2016 made it a North American leader in chlor-alkali and PVC. Today, Westlake has two defined segments: performance and essential materials, and housing and infrastructure products. The HIP segment began operating in 2022 following a series of acquisitions in the building products space. The firm aims to maximize the value of its chemical production by integrating with the HIP segment, realizing the higher margins of finished commercial goods.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: